Sorrento gets FDA go ahead for STI-6643 trial in solid tumor
March 02 2021 - 9:10AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Sorrento Therapeutics (NASDAQ:SRNE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sorrento Therapeutics (NASDAQ:SRNE)
Historical Stock Chart
From Sep 2023 to Sep 2024